柴芍六君子汤治疗肝脾不和型慢性胃炎60例

ChaiShao LiuJunZi Decoction in Treating 60 Cases of Chronic Gastritis of Liver-spleen Disharmony Pattern

目的:观察柴芍六君子汤治疗肝脾不和型慢性胃炎的临床疗效。方法:将120例患者随机分为观察组和对照组,每组60例。对照组口服氟哌噻吨美利曲辛片(黛力新),1片/次,2次/d;观察组口服柴芍六君子汤,1剂/d。2组均连续治疗2个月。比较2组治疗前后的焦虑自评量表(SAS)与抑郁自评量表(SDS)评分、临床疗效及幽门螺杆菌(Hp)根除率。结果:SAS、SDS评分治疗前后2组组内比较,差异有统计学意义(P<0.05);治疗后2组组间比较差异有统计学意义(P<0.05)。总有效率观察组为91.7%,对照组为78.3%,2组比较差异有统计学意义(P<0.05)。Hp根除率观察组为86.5%,对照组为79.4%,2组比较差异无统计学意义(P>0.05)。结论:柴芍六君汤治疗肝脾不和型慢性胃炎临床疗效显著,可改善患者精神状态。

Objective： To observe clinical effects of ChaiShao LiuJunZi decoction in treating chronic gastritisof liver-spleen disharmony pattern. Methods： All 120 patients were randomly allocated to the observation group andthe control group, 60 cases each group. The control group accepted oral deanxit, one tablet once, twice each day; theobservation group ChaiShao LiuJunZi decoction, one dose each day. Both groups were treated for two months con-secutively. Hp eradication rate, clinical effects, SDS scales and SAS were compared in both groups before and aftertreating. Results： The difference had statistical meaning in the comparisons of SAS and SDS scales before and aftertreating within two groups（P〈0.05）; the difference was statistically significant in the comparisons between bothgroups after treating（P〈0.05）. Total effective rate of the observation group was 91.7%, higher than 78.3% of thecontrol group, and the difference showed statistical meaning（P〈0.05）. Hp eradication rate of the observation groupwas 86.5%, higher than 79.4% of the control group, and the difference had no statistical meaning（P〉0.05）. Conclu-sion： ChaiShao LiuJunZi decoction is effective in treating chronic gastritis of liver-spleen disharmony pattern, whichcould improve mental state of the patients.